Your browser doesn't support javascript.
loading
[Factors associated with death and attrition in HIV-infected children under initial antiretroviral therapy in Guangxi Zhuang Autonomous Region, 2004 - 2019].
Zhou, Y S; Luo, L H; Lin, M; Chen, H L; Huang, J H; Zhu, Q Y; Chen, H H; Shen, Z Y; Li, J J; Feng, Y; Li, D; Liao, L J; Xing, H; Shao, Y M; Ruan, Y H; Lan, Guanghua.
Afiliación
  • Zhou YS; State Key Laboratory of Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
  • Luo LH; Guangxi Key Laboratory for Major Infectious Diseases Prevention and Control and Biosafety Emergency Response,Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention,Nanning 530028, China.
  • Lin M; Guangxi Key Laboratory for Major Infectious Diseases Prevention and Control and Biosafety Emergency Response,Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention,Nanning 530028, China.
  • Chen HL; State Key Laboratory of Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
  • Huang JH; Guangxi Key Laboratory for Major Infectious Diseases Prevention and Control and Biosafety Emergency Response,Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention,Nanning 530028, China.
  • Zhu QY; Guangxi Key Laboratory for Major Infectious Diseases Prevention and Control and Biosafety Emergency Response,Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention,Nanning 530028, China.
  • Chen HH; Guangxi Key Laboratory for Major Infectious Diseases Prevention and Control and Biosafety Emergency Response,Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention,Nanning 530028, China.
  • Shen ZY; Guangxi Key Laboratory for Major Infectious Diseases Prevention and Control and Biosafety Emergency Response,Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention,Nanning 530028, China.
  • Li JJ; Guangxi Key Laboratory for Major Infectious Diseases Prevention and Control and Biosafety Emergency Response,Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention,Nanning 530028, China.
  • Feng Y; State Key Laboratory of Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
  • Li D; State Key Laboratory of Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
  • Liao LJ; State Key Laboratory of Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
  • Xing H; State Key Laboratory of Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
  • Shao YM; State Key Laboratory of Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
  • Ruan YH; State Key Laboratory of Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
  • Lan G; Guangxi Key Laboratory for Major Infectious Diseases Prevention and Control and Biosafety Emergency Response,Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention,Nanning 530028, China.
Zhonghua Liu Xing Bing Xue Za Zhi ; 43(9): 1430-1435, 2022 Sep 10.
Article en Zh | MEDLINE | ID: mdl-36117350
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por VIH / Fármacos Anti-VIH Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Child / Female / Humans / Male País/Región como asunto: Asia Idioma: Zh Revista: Zhonghua Liu Xing Bing Xue Za Zhi Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por VIH / Fármacos Anti-VIH Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Child / Female / Humans / Male País/Región como asunto: Asia Idioma: Zh Revista: Zhonghua Liu Xing Bing Xue Za Zhi Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: China